当前位置: 首页 > 期刊 > 《上海医药》 > 202021
编号:13826080
临床药师对1例红斑狼疮合并诺卡菌感染治疗的药学监护——药物治疗中的“两点论”和“重点论”(4)
http://www.100md.com 2020年7月25日 《上海医药》 202021
     [2] Kuter DJ, Tillotson GS. Hematologic effects of antimicrobials: focus on the oxazolidinone linezolid[J]. Pharmacotherapy, 2001, 21(8): 1010-1013.

    [3] Halpern M. Linezolid-induced pancytopenia[J]. Clin Infect Dis, 2002, 35(3): 347-348.

    [4] Nimeiri HS, Nemiary DS. Challenges with linezolid therapy and reversible pancytopenia[J]. Ann Hematol, 2003, 82(8): 533.

    [5] Lakhani N, Thompson W, Bombassaro AM. Probable linezolid-induced pancytopenia[J]. Can J Infect Dis Med Microbiol, 2005, 16(5): 286-288.

    [6] Vinh DC, Rubinstein E. Linezolid: a review of safety and tolerability[J]. J Infect, 2009, 59(Suppl 1): S59-S74.

    [7] 汪復, 张婴元. 实用抗感染治疗学[M]. 北京: 人民卫生出版社, 2004: 239.

    [8] Rupprecht TA, Pfister HW. Clinical experience with linezolid for the treatment of central nervous system infections[J]. Eur J Neurol, 2005, 12(7): 536-542.

    [9] Ntziora F, Falagas ME. Linezolid for the treatment of patients with central nervous system infection[J]. Ann Pharmacother, 2007, 41(2): 296-308., http://www.100md.com(叶晓芬 张捷青 金美玲)
上一页1 2 3 4